SLI381: a long-acting psychostimulant preparation for the treatment of attention-deficit hyperactivity disorder

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.10, Iss.11, 2001-11, pp. : 2003-2011

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Review of long-acting stimulants in the treatment of attention deficit hyperactivity disorder

By Weisler Richard H

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 6, 2007-04 ,pp. : 745-758

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic Variability of Long-Acting Stimulants in the Treatment of Children and Adults with Attention-Deficit Hyperactivity Disorder

By Ermer James C.

CNS Drugs, Vol. 24, Iss. 12, 2010-12 ,pp. : 1009-1025

Adis International

Access to resources Recommend Favorite

SLI 381 appears suitable for once-daily dosing in paediatric patients with attention-deficit hyperactivity disorder

Inpharma, Vol. 1, Iss. 1393, 2003-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Long-Acting Methylphenidate-OROS in Youths with Attention-Deficit Hyperactivity Disorder Suboptimally Controlled with Immediate-Release Methylphenidate: A Study of Cost Effectiveness in The Netherlands

By Faber Adrianne Michel van Agthoven

CNS Drugs, Vol. 22, Iss. 2, 2008-01 ,pp. : 157-170

Adis International

Access to resources Recommend Favorite

Role of Zinc in the Pathogenesis of Attention-Deficit Hyperactivity Disorder: Implications for Research and Treatment

By Lepping Peter

CNS Drugs, Vol. 24, Iss. 9, 2010-09 ,pp. : 721-728

Adis International

Access to resources Recommend Favorite